These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31331281)

  • 1. A systematic review of the epidemiology of hepatitis A in Africa.
    Patterson J; Abdullahi L; Hussey GD; Muloiwa R; Kagina BM
    BMC Infect Dis; 2019 Jul; 19(1):651. PubMed ID: 31331281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
    Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
    PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
    Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region.
    Itani T; Jacobsen KH; Nguyen T; Wiktor SZ
    Vaccine; 2014 Oct; 32(46):6067-74. PubMed ID: 25236586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A shifting epidemiology in the Middle East and Africa.
    Tufenkeji H
    Vaccine; 2000 Feb; 18 Suppl 1():S65-7. PubMed ID: 10683552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review.
    Andani A; van Elten TM; Bunge EM; Marano C; Salgado F; Jacobsen KH
    Expert Rev Vaccines; 2020 Sep; 19(9):795-805. PubMed ID: 32955965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
    Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
    J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.
    Jacobsen KH; Wiersma ST
    Vaccine; 2010 Sep; 28(41):6653-7. PubMed ID: 20723630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A virus in the Middle East and North Africa region: a new challenge.
    Melhem NM; Talhouk R; Rachidi H; Ramia S
    J Viral Hepat; 2014; 21(9):605-15. PubMed ID: 25040644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Southern Tunisia: A still high endemicity area for hepatitis A.
    Neffatti H; Lebraud P; Hottelet C; Gharbi J; Challouf T; Roque-Afonso AM
    PLoS One; 2017; 12(4):e0175887. PubMed ID: 28426700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A seroprevalence in Western Cape Province, South Africa: Are we in epidemiological transition?
    Enoch A; Hardie DR; Hussey GD; Kagina BM
    S Afr Med J; 2019 Apr; 109(5):314-318. PubMed ID: 31131797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa.
    Koroglu M; Jacobsen KH; Demiray T; Ozbek A; Erkorkmaz U; Altindis M
    J Infect Public Health; 2017; 10(5):513-517. PubMed ID: 28162965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and incidence of hepatitis A in Southeast Asia: A systematic review.
    Hernandez-Suarez G; Saha D; Lodroño K; Boonmahittisut P; Taniwijaya S; Saha A; Badur S; Poovorawan Y
    PLoS One; 2021; 16(12):e0258659. PubMed ID: 34851983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis A in Latin America: The current scenario.
    Ré VE; Ridruejo E; Fantilli AC; Moutinho BD; Pisano MB; Pessoa MG
    Rev Med Virol; 2024 Jul; 34(4):e2566. PubMed ID: 38970225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico.
    Trujillo-Ochoa JL; Viera-Segura O; Fierro NA
    Ann Hepatol; 2019; 18(1):14-22. PubMed ID: 31113583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide Hospital-Based Seroprevalence of Hepatitis A and Hepatitis E Virus in Bangladesh.
    Khan AI; Salimuzzaman M; Islam MT; Afrad MH; Shirin T; Jony MHK; Alam MA; Rahman M; Flora MS; Qadri F
    Ann Glob Health; 2020 Mar; 86(1):29. PubMed ID: 32211299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A Seroprevalence in Mogadishu, Somalia.
    Akbulut UE; Arslan E
    J Trop Pediatr; 2022 Jan; 68(1):. PubMed ID: 35134249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and predictors of hepatitis A infection in Nigerian children.
    Ikobah JM; Okpara HC; Ekanem EE; Udo JJ
    Pan Afr Med J; 2015; 20():120. PubMed ID: 26090068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012).
    Pereira S; Linhares I; Neves AF; Almeida A
    Viruses; 2014 Mar; 6(3):1336-45. PubMed ID: 24638206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.